THE ALS ASSOCIATION INC WISCONSIN logo

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

THE ALS ASSOCIATION INC WISCONSIN

Funding Amount

Application budgets not limited; must reflect actual needs of proposed project

Deadline

September 28, 2026

173 days left

Grant Type

foundation

Overview

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

Funder: National Institutes of Health (NIH)

Description: This funding opportunity supports investigators in pursuing translational activities and clinical studies to advance the development of therapeutic and diagnostic devices for nervous system disorders.

    Supported Activities

  • Implementation of clinical prototype devices
  • Non-clinical safety and effectiveness testing
  • Design verification and validation activities
  • Obtaining an Investigational Device Exemption for a Significant Risk study
  • IRB approval for a Non-Significant Risk study
  • Subsequent clinical study, feasibility, or pivotal clinical trial support (as appropriate)

    Clinical Trial Status

  • Clinical trials are optional

    Award Parameters

  • Application budgets are not limited but need to reflect the actual needs of the proposed project

How to Apply

Application Deadlines

  • May 28, 2026
  • September 28, 2026

    Application Process

  • Submit through NIH grants portal
  • Full proposal submission (LOI requirements not specified in provided text)
  • See Information for Grant Applicants and Awardees page for detailed application instructions

Focus Areas & Funding Uses

Fields of Work

science-research

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.